Azithromycin quantitation in human plasma by high-performanee liquid chromatography coupled to electrospray mass spectrometry: Application to bioequivalence study

Journal of Chromatographic Science

Volumn 46, Issue 6, 2008, Pages 479-484

  Xu, Fengguo ^a   Zhang, Zunjian ^a   Bian, Zuwei ^a   Tian, Yuan ^a   Jiao, Haoyan ^a   Liu, Ying ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 47549094697     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/46.6.479     Document Type: Article

References (14)

1. J. Retsema, A. Girard, W. Schelkly, M. Manousos, M. Anderson, G. Bright, R. Borovoy, L. Brennan, and R. Mason. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob. Agents Chemother. 31: 1939-47 (1987).
2. M. Rylander and H.O. Hallander. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin, and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum. Scand. J. Infect. Dis. Suppl. 53: 12-17 (1988).
3. L.E. Bermudez and L.S. Young. Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex. Antimicrob. Agents Chemother. 32: 1149-1153 (1988).
4. Helsinki University Central Hospital, Finland. Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species. J. Antimicrob. Chemother. 25 Suppl A: 115-121 (1990).
5. P. Leophonte. Effects of azithromycin on the virulence of Pseudomonas aeruginosa. Pathol. Biol. 43: 551-5553 (1995).
6. C. Stubbs, J.M. Haigh, and I. Kanfer. Determination of erythromycin in serum and urine by high-performance liquid chromatography with ultraviolet detection. J. Pharm. Sci. 74: 1126-1128 (1985).
7. T.J. Sastre and H.J. Guchelaar. Quantitative determination of the macrolide antibiotics erythromycin, roxithromycin, azithromycin, and clarithromycin in human serum by high-performance liquid chromatography using pre-column derivatization with 9-fluorenylmethyloxycarbonyl chloride and fluorescence detection. J. Chromatogr. B Biomed. Sci. Appl. 720: 89-97 (1998).
8. R.M. Shepard, G.S. Duthu, R.A. Ferraina, and M.A. Mullins. High-performance liquid chromatographic assay with electrochemical detection for azithromycin in serum and tissues. J. Chromatogr. 565: 321-37 (1991).
9. H. Toreson and B.M. Eriksson. Determination of erythromycin in gastric juice and blood plasma by liquid chromatography and electrochemical detection. J. Chromatogr. B 673: 81-89 (1995).
10. M. Hedenmo and B.M. Eriksson. Liquid chromatographic determination of the macrolide antibiotics roxithromycin and clarithromycin in plasma by automated solid-phase extraction and electrochemical detection. J. Chromatogr. A 692: 161-166 (1995).
11. F. Kees, S. Spangler, and M. Wellenhofer. Determination of macrolides in biological matrices by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. A 812: 287-393 (1998).
12. R. Gandhi, C.L. Kaul, and R. Panchagnula. Validated LC method for in-vitro analysis of azithromycin using electrochemical detection. J. Pharm. Biomed. Anal. 23: 1073-1078 (2000).
13. C. Taninaka, H. Ohtani, E. Hanada, H. Kotaki, H. Sato, and T. Iga. Determination of erythromycin, clarithromycin, roxithromycin, and azithromycin in plasma by high-performance liquid chromatography with amperometric detection. J. Chromatogr. B 738: 405-411 (2000).
14. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), May 2001.